Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
作者信息
Bangsgaard Nannie, Fischer Louise A N, Zachariae Claus
机构信息
Department of Dermato-allergology, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
出版信息
Contact Dermatitis. 2016 Jun;74(6):378-9. doi: 10.1111/cod.12547.
PMID:27133629
Abstract
摘要
相似文献
1
Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
Contact Dermatitis. 2016 Jun;74(6):378-9. doi: 10.1111/cod.12547.
2
Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.
Contact Dermatitis. 2015 Dec;73(6):366-7. doi: 10.1111/cod.12476.
3
Allergic contact dermatitis to topical brimonidine.
Australas J Dermatol. 2015 Aug;56(3):235. doi: 10.1111/ajd.12299.
4
Case Report: Allergic Contact Dermatitis to Topical Brimonidine Demonstrated With Patch Testing: Insights on Evaluation of Brimonidine Sensitization.
J Cutan Med Surg. 2018 Nov/Dec;22(6):636-638. doi: 10.1177/1203475418789020. Epub 2018 Jul 18.
5
[Brimonidine (Mirvaso), dermal use].
J Pharm Belg. 2015 Jun(2):45-6.
6
[Allergic contact dermatitis to Mirvaso (brimonidine tartrate)].
Ann Dermatol Venereol. 2017 Jan;144(1):86-87. doi: 10.1016/j.annder.2016.08.004. Epub 2016 Sep 28.
7
Dermatitis medicamentosa: severe rebound erythema secondary to topical brimonidine in rosacea.
Dermatol Online J. 2015 Jan 1;21(3):13030/qt93n0n7pp.
8
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28.
9
Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea.
J Drugs Dermatol. 2016 Jun 1;15(6):763-5.
10
Primum non nocere; the importance of evaluating the effect of treatment and considering side effects.
Contact Dermatitis. 2021 Feb;84(2):121-122. doi: 10.1111/cod.13675. Epub 2020 Aug 13.
引用本文的文献
1
Primum non nocere; the importance of evaluating the effect of treatment and considering side effects.
Contact Dermatitis. 2021 Feb;84(2):121-122. doi: 10.1111/cod.13675. Epub 2020 Aug 13.
2
Contact Allergy: A Review of Current Problems from a Clinical Perspective.
Int J Environ Res Public Health. 2018 May 29;15(6):1108. doi: 10.3390/ijerph15061108.
3
Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?
J Clin Aesthet Dermatol. 2017 Jul;10(7):28-32. Epub 2017 Jul 1.
Zotero 插件